Crestor (Rosuvastatin) FDA Prescribing Info & Approval Status
FDA approved Crestor on August 12, 2003 (NDA 021366) for hyperlipidemia. Covers doses, black box warning, generics since 2016, and global approvals.
Rosuvastatin: Regulatory History
1 source-based articles maintained by the HealthRX.com Editorial Team.
1articles
1topic areas covered
Jan 15, 2025latest review
Rosuvastatin: Regulatory History library
Showing 1 of 1 clinical reviews.